Nuclera and leadXpro have entered a scientific partnership to develop [...]

FundaMental Pharma GmbH will present new preclinical data on its [...]

Oncoinvent will present final 24-month follow-up data from its Phase [...]

Scribe Therapeutics has achieved a second success milestone in its [...]

Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]

New England Biolabs has launched the Monarch Mag Cell-free DNA [...]

Nucleome Therapeutics has appointed Michelle Morrow as chief scientific officer, [...]

Alto Neuroscience has completed patient enrollment in its Phase 2 [...]

Full results from the Phase 3 KALOS and LOGOS trials [...]

Evogene Ltd and Shanghai Lishan Biopharmaceuticals Co. have entered into [...]